Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy.

Elgedawy GA, Adbelmoneum RA, Aldesoky AI, Mashal SS, Awad AE, Elabd NS, Helal ML.

Open source

DOI
10.1186/s12885-026-15967-7
Published
2026-09-08
Container
BMC Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-15967-7,
  title = {Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy.},
  author = {Elgedawy GA and  Adbelmoneum RA and  Aldesoky AI and  Mashal SS and  Awad AE and  Elabd NS and  Helal ML.},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-15967-7},
  url = {https://doi.org/10.1186/s12885-026-15967-7}
}

RIS

TY  - JOUR
TI  - Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy.
AU  - Elgedawy GA
AU  -  Adbelmoneum RA
AU  -  Aldesoky AI
AU  -  Mashal SS
AU  -  Awad AE
AU  -  Elabd NS
AU  -  Helal ML.
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-15967-7
UR  - https://doi.org/10.1186/s12885-026-15967-7
ER  - 

APA

GA, E., RA, A., AI, A., SS, M., AE, A., NS, E., & ML., H. (2026). Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy.. BMC Cancer. https://doi.org/10.1186/s12885-026-15967-7

Source records